Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer

Int J Mol Sci. 2022 Feb 26;23(5):2603. doi: 10.3390/ijms23052603.

Abstract

Renal oncocytoma represents the most common type of benign neoplasm that is an increasing concern for urologists, oncologists, and nephrologists due to its difficult differential diagnosis and frequent overtreatment. It displays a variable neoplastic parenchymal and stromal architecture, and the defining cellular element is a large polygonal, granular, eosinophilic, mitochondria-rich cell known as an oncocyte. The real challenge in the oncocytoma treatment algorithm is related to the misdiagnosis due to its resemblance, at an initial radiological assessment, to malignant renal cancers with a completely different prognosis and medical treatment. Unfortunately, percutaneous renal biopsy is not frequently performed due to the possible side effects related to the procedure. Therefore, the majority of oncocytoma are diagnosed after the surgical operation via partial or radical nephrectomy. For this reason, new reliable strategies to solve this issue are needed. In our review, we will discuss the clinical implications of renal oncocytoma in daily clinical practice with a particular focus on the medical diagnosis and treatment and on the potential of novel promising molecular biomarkers such as circulating microRNAs to distinguish between a benign and a malignant lesion.

Keywords: diagnosis; molecular biomarkers; molecular profiling; oncocytoma; partial nephrectomy; radical nephrectomy; renal function; treatment.

Publication types

  • Review

MeSH terms

  • Adenoma, Oxyphilic* / diagnosis
  • Carcinoma, Renal Cell* / pathology
  • Diagnosis, Differential
  • Humans
  • Kidney Neoplasms* / pathology
  • Nephrectomy

Supplementary concepts

  • Oncocytoma, renal